source
- Biopharma hiring surges in Massachusetts and California, with science/R&D and clinical roles leading demandBioSpace data shows that biopharma job postings on its site rose 17% between January and August 2026, signaling a broad increase in employment opportunities. Massachusetts and California dominate…
- Bristol Myers ends $100M Phase 1 cancer ADC programBristol Myers Squibb announced it has discontinued development of its Phase 1 antibody-drug conjugate candidate BMS-986497/ORM-6151. The decision follows a review of early clinical data, leading t…